Showing results (181-190 of 262) with videos related to
Sort By:
Pageof 27
The Journal of Infection|November 1, 2015
HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patternsAdrien Quintela, Vanessa Escuret, Sandrine Roux, et al.Cancer|June 30, 2012
Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patientsMauricette Michallet, Karine Goldet, Mohamad Sobh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroupThomas Prébet, Nicolas Boissel, Sarah Reutenauer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2019
Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALLAurore Touzart, Etienne Lengliné, Mehdi Latiri, et al.Investigational New Drugs|April 27, 2011
Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemiaSimona Lapusan, Maria B Vidriales, Xavier Thomas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2004
Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trialXavier Thomas, Jean-Michel Boiron, Françoise Huguet, et al.Haematologica|December 10, 2020
Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D-NPM1 mutations by digital polymerase chain reaction: feasibility and clinical useAuriane Lesieur, Xavier Thomas, Olivier Nibourel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 studyCecile Pautas, Fatiha Merabet, Xavier Thomas, et al.Blood|December 26, 2008
NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) studyVahid Asnafi, Agnès Buzyn, Sandrine Le Noir, et al.Blood|March 12, 2005
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 studySergio Amadori, Stefan Suciu, Ulrich Jehn, et al.Pageof 27